TY - JOUR
T1 - The effect of modafinil on passive avoidance memory, brain level of BDNF and oxidative stress markers in sepsis survivor rats
AU - Garbossa, Leandro
AU - Joaquim, Larissa
AU - Danielski, Lucineia Gainski
AU - Goldim, Mariana Pereira de Souza
AU - Machado, Richard Simon
AU - Metzker, Kiuanne
AU - Bernades, Gabriela
AU - Lanzzarin, Everton
AU - Bagio, Erick
AU - Farias, Adriele de
AU - Rosa, Naiana da
AU - Medeiros, Fabiana Durante de
AU - Carli, Raquel Jaconi de
AU - Oliveira, Bruna Hoffman
AU - Ferreira, Nivaldo Correia
AU - Palandi, Juliete
AU - Bobinski, Franciane
AU - Martins, Daniel Fernandes
AU - Fortunato, Jucelia Jeremias
AU - Barichello, Tatiana
AU - Petronilho, Fabricia
N1 - Publisher Copyright:
© 2022 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2024
Y1 - 2024
N2 - Propose/aim of study: Modafinil (MD) is a psychostimulant drug used off-label and cognitive dysfunction may be a significant emerging treatment target for this drug. The objective of this study was to evaluate the effect of MD on the neurochemical parameters and memory impairment of rats submitted to sepsis by cecal ligation and perforation (CLP). Material and method: Male Wistar rats (250–350g) were submitted to CLP, or sham as control, and divided into the sham + water, sham + MD (300 mg/kg), CLP + water, and CLP + MD (300 mg/kg) groups. Ten days after the administration of MD and CLP, the rats were submitted to a memory test by passive avoidance apparatus being sacrificed. The nitrite and nitrate (N/N) concentration, myeloperoxidase (MPO) and catalase (CAT) activity, lipid and protein oxidative damage, and brain-derived neurotrophic factor (BDNF) levels were measured in the prefrontal cortex and hippocampus. Results: The passive avoidance test verified an increase in the latency time compared training and test section in the groups sham + water and CLP + MD. Decreased N/N concentration and MPO activity were verified in the prefrontal cortex of rats submitted to CLP and MD treatment, as well as reduced protein and lipid oxidative damage in the hippocampus, which was accompanied by increased CAT activity and BDNF levels.Conclusion: Our data indicate the role of MD in attenuating oxidative stress parameters, the alteration of BDNF, and an improvement in memory impairment in rats ten days after induction of sepsis.
AB - Propose/aim of study: Modafinil (MD) is a psychostimulant drug used off-label and cognitive dysfunction may be a significant emerging treatment target for this drug. The objective of this study was to evaluate the effect of MD on the neurochemical parameters and memory impairment of rats submitted to sepsis by cecal ligation and perforation (CLP). Material and method: Male Wistar rats (250–350g) were submitted to CLP, or sham as control, and divided into the sham + water, sham + MD (300 mg/kg), CLP + water, and CLP + MD (300 mg/kg) groups. Ten days after the administration of MD and CLP, the rats were submitted to a memory test by passive avoidance apparatus being sacrificed. The nitrite and nitrate (N/N) concentration, myeloperoxidase (MPO) and catalase (CAT) activity, lipid and protein oxidative damage, and brain-derived neurotrophic factor (BDNF) levels were measured in the prefrontal cortex and hippocampus. Results: The passive avoidance test verified an increase in the latency time compared training and test section in the groups sham + water and CLP + MD. Decreased N/N concentration and MPO activity were verified in the prefrontal cortex of rats submitted to CLP and MD treatment, as well as reduced protein and lipid oxidative damage in the hippocampus, which was accompanied by increased CAT activity and BDNF levels.Conclusion: Our data indicate the role of MD in attenuating oxidative stress parameters, the alteration of BDNF, and an improvement in memory impairment in rats ten days after induction of sepsis.
KW - memory
KW - modafinil
KW - oxidative stress
KW - Sepsis
UR - https://www.scopus.com/pages/publications/85144016027
UR - https://www.scopus.com/pages/publications/85144016027#tab=citedBy
U2 - 10.1080/00207454.2022.2154076
DO - 10.1080/00207454.2022.2154076
M3 - Article
C2 - 36448768
AN - SCOPUS:85144016027
SN - 0020-7454
VL - 134
SP - 849
EP - 857
JO - International Journal of Neuroscience
JF - International Journal of Neuroscience
IS - 8
ER -